Multiprofile Hospital For Active Treatment Dr. Hristo Stambolski EOOD
- Address
- lock Available on a paid plan
Psychiatry and Psychology – Mental Disorders
The Department of Psychiatry at Multiprofile Hospital for Active Treatment Dr. Hristo Stambolski EOOD is dedicated to improving care for patients with schizophrenia, bipolar disorder, and major depressive disorder. Current research evaluates new therapies that target core symptoms, enhance daily functioning, and monitor long‑term safety.
- Reducing negative and cognitive symptoms in schizophrenia
- Managing manic episodes associated with bipolar I disorder
- Alleviating depressive episodes in bipolar I or II disorder
- Treating major depressive disorder with novel agents
- Assessing long‑term safety of adjunctive treatments for schizophrenia
Ten active trials, overseen by five investigators, are underway at the Kazanlak site, contributing valuable data to the European mental‑health research landscape.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Xenon Pharmaceuticals Inc.2active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Xenon Pharmaceuticals Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Multiprofile Hospital For Active Treatment Dr. Hristo Stambolski EOOD
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Long-term, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Azetukalner in Patients with Bipolar I or II Depression | Xenon Pharmaceuticals Inc. | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azetukalner | 2 | Unknown | 2026-06-05 | 2026-06-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.